Rolando Velazquez
Medical · McAllen, TXNPI 1417166612
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 773 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 773 payments — averaging $16.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$2K
- Lilly USA, LLC$1K
- Dexcom, Inc.$846
- Bayer$813
- Amgen$730
- plus $5K from 28 others
What the payments were for
- Food & beverage$12,88899%
- Education$1341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 131 | $2,145 |
| AstraZeneca | 84 | $1,893 |
| Lilly USA, LLC | 89 | $1,175 |
| Dexcom, Inc. | 52 | $846 |
| Bayer | 42 | $813 |
| Amgen(2 entities) | 55 | $730 |
| Merck | 32 | $595 |
| GSK | 31 | $570 |
| Boehringer Ingelheim | 36 | $567 |
| Amarin Pharma, Inc. | 33 | $537 |
| Johnson & Johnson | 30 | $513 |
| AbbVie | 35 | $420 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 32 | $410 |
| Astellas Pharma US Inc | 12 | $281 |
| Novartis | 11 | $230 |
| Sanofi-aventis U.S. LLC | 11 | $188 |
| Urovant Sciences Inc | 5 | $129 |
| Esperion Therapeutics, Inc. | 7 | $119 |
| Phathom Pharmaceuticals, Inc. | 7 | $112 |
| Pfizer | 5 | $109 |
| Sumitomo Pharma America, Inc. | 4 | $98 |
| Abbott | 5 | $91 |
| Averitas Pharma Inc. | 3 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $67 |
| Corcept Therapeutics | 3 | $66 |
| Kowa Pharmaceuticals America, Inc. | 2 | $40 |
| Arbor Pharmaceuticals, Inc. | 3 | $40 |
| Mannkind Corporation | 2 | $38 |
| Insulet Corporation | 2 | $32 |
| Scpharmaceuticals Inc. | 1 | $23 |
| Redhill Biopharma Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Intuity Medical Inc | 1 | $14 |
| Cequr Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,021 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.
Other medical in McAllen
- Jason HenslerMcAllen$66K
- Edgar GarciaMcAllen$17K
- Claudia MaldonadoMcAllen$15K
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.